Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis Type II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03232892
What this trial is testing

Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of California, San Francisco 1
Not applicableStudy completedNCT03672838
What this trial is testing

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Who this might be right for
Neurofibromatosis 1 and 2 (NF1 and NF2)
NYU Langone Health 33
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Very early researchStudy completedNCT00863122
What this trial is testing

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Who this might be right for
Vestibular SchwannomaNF2Neurofibromatosis 2+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)Study completedNCT03326388
What this trial is testing

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaOptic Nerve Glioma
Great Ormond Street Hospital for Children NHS Foundation Trust 14
Testing effectiveness (Phase 2)Ended earlyNCT02177825
What this trial is testing

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

Who this might be right for
Plexiform Neurofibromas
St. Justine's Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT04374305
What this trial is testing

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more
Scott R. Plotkin, MD, PhD 109
Not applicableUnknownNCT05821790
What this trial is testing

Role of the Tumor Microenvironment in Aggressive Meningiomas

Who this might be right for
Meningioma
Assistance Publique - Hôpitaux de Paris 40
Early research (Phase 1)Active Not RecruitingNCT06104488
What this trial is testing

Avutometinib for People With Solid Tumor Cancers

Who this might be right for
Refractory CancerCNS TumorsCNS Tumor, Adult+12 more
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT01968590
What this trial is testing

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1 (NF1)
University of Utah 26
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Large-scale testing (Phase 3)Ended earlyNCT00427583
What this trial is testing

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Looking for participantsNCT05180825
What this trial is testing

Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy

Who this might be right for
Grade 1 GliomaMixed Glio-neuronal TumorsPleomorphic Xanthoastrocytoma
University Hospital, Strasbourg, France 134
Very early researchEnded earlyNCT02282917
What this trial is testing

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Who this might be right for
Vestibular SchwannomaMeningiomaAcoustic Neuroma+1 more
Massachusetts Eye and Ear Infirmary 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT01362803
What this trial is testing

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Who this might be right for
Neurofibromatosis 1Neurofibromatosis Type 1NF1+1 more
National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713745
What this trial is testing

Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+4 more
Beijing Tiantan Hospital 200
Not applicableEnded earlyNCT01736267
What this trial is testing

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 3
Next Page